vs
NATIONAL RESEARCH CORP（NRC）与OneMedNet Corp（ONMD）财务数据对比。点击上方公司名可切换其他公司
NATIONAL RESEARCH CORP的季度营收约是OneMedNet Corp的39.5倍（$35.2M vs $890.0K）。NATIONAL RESEARCH CORP净利率更高（5.1% vs -352.8%，领先357.9%）。OneMedNet Corp同比增速更快（3323.1% vs -4.6%）。NATIONAL RESEARCH CORP自由现金流更多（$6.1M vs $-1.7M）。过去两年OneMedNet Corp的营收复合增速更高（89.4% vs -0.2%）
NRC Health（原国家研究公司）是一家美国医疗健康企业，1981年成立，总部位于内布拉斯加州林肯市。公司主要在美加两国提供医疗健康相关产品及订阅式解决方案，深耕区域医疗健康服务领域。
OneMedNet Corp是一家总部位于美国的医疗科技企业，提供面向医学影像与患者健康信息的安全云数据共享及工作流解决方案，服务覆盖医疗机构、支付方及生命科学领域机构，核心运营市场为北美地区。
NRC vs ONMD — 直观对比
营收规模更大
NRC
是对方的39.5倍
$890.0K
营收增速更快
ONMD
高出3327.7%
-4.6%
净利率更高
NRC
高出357.9%
-352.8%
自由现金流更多
NRC
多$7.8M
$-1.7M
两年增速更快
ONMD
近两年复合增速
-0.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $35.2M | $890.0K |
| 净利润 | $1.8M | $-3.1M |
| 毛利率 | — | 20.7% |
| 营业利润率 | 13.3% | -353.4% |
| 净利率 | 5.1% | -352.8% |
| 营收同比 | -4.6% | 3323.1% |
| 净利润同比 | -72.6% | -32.3% |
| 每股收益（稀释后） | $49.58 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NRCONMD
| Q4 25 | $35.2M | $890.0K | ||
| Q3 25 | $34.6M | $177.0K | ||
| Q2 25 | $34.0M | $155.0K | ||
| Q1 25 | $33.6M | $137.0K | ||
| Q4 24 | $36.9M | $26.0K | ||
| Q3 24 | $35.8M | $142.0K | ||
| Q2 24 | $35.0M | $227.0K | ||
| Q1 24 | $35.3M | $248.0K |
净利润NRCONMD
| Q4 25 | $1.8M | $-3.1M | ||
| Q3 25 | $4.1M | $-741.0K | ||
| Q2 25 | $-106.0K | $3.0M | ||
| Q1 25 | $5.8M | $-1.9M | ||
| Q4 24 | $6.6M | $-2.4M | ||
| Q3 24 | $5.7M | $-2.1M | ||
| Q2 24 | $6.2M | $-3.6M | ||
| Q1 24 | $6.4M | $-2.1M |
毛利率NRCONMD
| Q4 25 | — | 20.7% | ||
| Q3 25 | — | -125.4% | ||
| Q2 25 | — | -155.5% | ||
| Q1 25 | — | -163.5% | ||
| Q4 24 | — | -100.0% | ||
| Q3 24 | — | -59.2% | ||
| Q2 24 | — | -44.9% | ||
| Q1 24 | — | -27.8% |
营业利润率NRCONMD
| Q4 25 | 13.3% | -353.4% | ||
| Q3 25 | 22.4% | -1262.7% | ||
| Q2 25 | 4.7% | -1331.0% | ||
| Q1 25 | 25.6% | -1623.4% | ||
| Q4 24 | 26.0% | -10438.5% | ||
| Q3 24 | 22.3% | -1645.1% | ||
| Q2 24 | 25.3% | -1081.1% | ||
| Q1 24 | 24.8% | -847.2% |
净利率NRCONMD
| Q4 25 | 5.1% | -352.8% | ||
| Q3 25 | 11.9% | -418.6% | ||
| Q2 25 | -0.3% | 1923.9% | ||
| Q1 25 | 17.2% | -1388.3% | ||
| Q4 24 | 17.8% | -9126.9% | ||
| Q3 24 | 15.9% | -1449.3% | ||
| Q2 24 | 17.6% | -1581.1% | ||
| Q1 24 | 18.0% | -850.4% |
每股收益（稀释后）NRCONMD
| Q4 25 | $49.58 | $-0.06 | ||
| Q3 25 | $0.18 | $-0.01 | ||
| Q2 25 | $-0.01 | $0.07 | ||
| Q1 25 | $0.25 | $-0.06 | ||
| Q4 24 | $0.27 | $-0.07 | ||
| Q3 24 | $0.24 | $-0.07 | ||
| Q2 24 | $0.26 | $-0.14 | ||
| Q1 24 | $0.27 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.1M | $585.0K |
| 总债务越低越好 | — | $220.0K |
| 股东权益账面价值 | $14.0M | $-3.0M |
| 总资产 | $134.9M | $2.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NRCONMD
| Q4 25 | $4.1M | $585.0K | ||
| Q3 25 | $2.2M | $149.0K | ||
| Q2 25 | $5.3M | $122.0K | ||
| Q1 25 | $2.5M | $144.0K | ||
| Q4 24 | $4.2M | $172.0K | ||
| Q3 24 | $3.5M | $1.9M | ||
| Q2 24 | $485.0K | $407.0K | ||
| Q1 24 | $1.7M | $174.0K |
总债务NRCONMD
| Q4 25 | — | $220.0K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $48.7M | $2.3M | ||
| Q2 24 | $33.3M | $2.4M | ||
| Q1 24 | $35.2M | — |
股东权益NRCONMD
| Q4 25 | $14.0M | $-3.0M | ||
| Q3 25 | $14.3M | $-3.9M | ||
| Q2 25 | $21.3M | $-3.8M | ||
| Q1 25 | $29.7M | $-16.6M | ||
| Q4 24 | $31.3M | $-15.9M | ||
| Q3 24 | $34.6M | $-14.3M | ||
| Q2 24 | $40.2M | $-19.2M | ||
| Q1 24 | $36.9M | $-15.7M |
总资产NRCONMD
| Q4 25 | $134.9M | $2.2M | ||
| Q3 25 | $135.7M | $1.5M | ||
| Q2 25 | $141.4M | $2.3M | ||
| Q1 25 | $135.2M | $1.7M | ||
| Q4 24 | $132.5M | $3.7M | ||
| Q3 24 | $131.8M | $4.4M | ||
| Q2 24 | $119.1M | $1.0M | ||
| Q1 24 | $120.9M | $750.0K |
负债/权益比NRCONMD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.95× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.2M | $-1.7M |
| 自由现金流经营现金流 - 资本支出 | $6.1M | $-1.7M |
| 自由现金流率自由现金流/营收 | 17.2% | -193.0% |
| 资本支出强度资本支出/营收 | 3.2% | 0.6% |
| 现金转化率经营现金流/净利润 | 3.99× | — |
| 过去12个月自由现金流最近4个季度 | $15.7M | — |
8季度趋势，按日历期对齐
经营现金流NRCONMD
| Q4 25 | $7.2M | $-1.7M | ||
| Q3 25 | $13.8M | $-1.6M | ||
| Q2 25 | $-1.1M | $-2.3M | ||
| Q1 25 | $6.6M | $-1.9M | ||
| Q4 24 | $6.4M | $-2.0M | ||
| Q3 24 | $9.4M | $-1.9M | ||
| Q2 24 | $6.8M | $-1.5M | ||
| Q1 24 | $12.0M | $-1.5M |
自由现金流NRCONMD
| Q4 25 | $6.1M | $-1.7M | ||
| Q3 25 | $10.2M | — | ||
| Q2 25 | $-4.1M | $-2.3M | ||
| Q1 25 | $3.7M | $-2.0M | ||
| Q4 24 | $1.9M | $-2.0M | ||
| Q3 24 | $7.8M | $-1.9M | ||
| Q2 24 | $1.5M | $-1.5M | ||
| Q1 24 | $7.9M | $-1.6M |
自由现金流率NRCONMD
| Q4 25 | 17.2% | -193.0% | ||
| Q3 25 | 29.4% | — | ||
| Q2 25 | -12.2% | -1475.5% | ||
| Q1 25 | 10.9% | -1425.5% | ||
| Q4 24 | 5.2% | -7811.5% | ||
| Q3 24 | 21.8% | -1346.5% | ||
| Q2 24 | 4.3% | -663.9% | ||
| Q1 24 | 22.4% | -626.2% |
资本支出强度NRCONMD
| Q4 25 | 3.2% | 0.6% | ||
| Q3 25 | 10.4% | 0.0% | ||
| Q2 25 | 8.8% | 1.9% | ||
| Q1 25 | 8.9% | 3.6% | ||
| Q4 24 | 12.0% | 134.6% | ||
| Q3 24 | 4.5% | 6.3% | ||
| Q2 24 | 15.0% | 0.4% | ||
| Q1 24 | 11.7% | 2.4% |
现金转化率NRCONMD
| Q4 25 | 3.99× | — | ||
| Q3 25 | 3.34× | — | ||
| Q2 25 | — | -0.77× | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | 1.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
